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Abstract   
Sprague Dawley rats over-consume calories over a 10 week period and develop diet-
induced obesity (c. 100g body weight differential vs controls) when fed a control 
pellet diet supplemented with chocolate Ensure liquid. Subsequent withdrawal of 
Ensure immediately reduces caloric intake by more than 50%, and results in weight 
loss, despite control pellet being available ad libitum. To assess the molecular 
underpinnings of this phenomenon, brains were processed for energy balance and 
food reward-related gene expression analysis at two time points, 24h and 4 days after 
the withdrawal of Ensure, when energy intake was suppressed. Gene expression levels 
in hypothalamic arcuate nucleus and forebrain nucleus accumbens were compared 
with rats pair-fed to the same energy intake, i.e. imposed negative energy balance, and 
to controls fed control pellet ad libitum throughout. Cumulative energy intake was 
approximately 50% lower across the 4 day post-Ensure period, giving rise to a small 
reduction in body weight although body adiposity and blood leptin remained elevated 
(c. 100% and 50%, respectively vs controls) in rats that had previously been fed 
Ensure. In contrast, pair-feeding reduced blood insulin and leptin by 33% and 55%, 
respectively. Hypothalamic expression of neuropeptide Y and agouti-related peptide 
was down-regulated at 24h in rats previously fed Ensure, indicative of the apparent 
counter-regulatory changes seen in diet-induced obesity, but was normalised between 
the 24h and 4 day time points. By contrast, the effect of cumulative negative energy 
balance in the pair-fed groups increased with time, up-regulating expression of the 
orexigenic neuropeptides. There was also a reduction of suppressor of cytokine 
signalling-3 gene expression in pair-fed groups where leptin levels were low. There 
were no changes in opioid, dopamine receptor or cannabinoid receptor expression in 
the nucleus accumbens. Feedback from diet-induced obesity appears to drive 
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voluntary hypophagia upon withdrawal of palatable diet, and to override signals from 
intake restriction that would otherwise set in train an anabolic drive.  
 
Keywords:  diet-induced obesity; reward; neuropeptide Y; agouti related peptide; 
SOCS3 
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1. Introduction 
Polygenic susceptibility and palatable diet challenge are the basis of rodent models of 
diet-induced obesity (DIO), mimicking aspects of the human condition. Some of the 
most interesting features of these models appear immediately after dietary 
manipulation [1], and are obviously diet-dependent. Accordingly, such manipulations 
frequently result in periods of elevated or suppressed caloric intake of variable 
duration and intensity that also have implications for body weight defence. The 
Sprague Dawley (SD) rat model of DIO, elegantly characterised by Levin and co-
workers in a series of seminal papers, e.g. [2], has a number of fascinating features, 
revealed by dietary manipulation. SD rats exhibit relatively limited upward or 
downward deflections in energy intake on switching between control diet and high 
energy (HE) pellet diet, and largely defend their HE-elevated body weight [2,3,4]. 
However, when SD rats are fed Ensure (EN) as a supplement to HE diet, initial high 
levels of energy intake decline but remain elevated relative to controls, apparently 
indefinitely [2,4], leading to additional accumulation of adipose tissue. Return to 
control diet, i.e. simultaneous withdrawal of both HE pellet diet and liquid EN, 
induces a prolonged voluntary hypocaloric intake episode and weight loss, although 
total normalisation of body weight may not be achieved [2,4]. Similar outcomes have 
been recorded with cafeteria feeding of palatable solid diets ([5,6] and references 
therein). 
 
Lengthy voluntary excursion into negative energy balance as a result of reduced 
caloric intake on withdrawal of EN is observed in unselected populations of rats [1,4], 
as well as in selected sub-groups of animals that are more or less susceptible to DIO, 
where the response in SD rats was first described [2]. There appears to be 
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‘recognition’ of excessive body weight and adiposity that suppresses energy intake 
once the over-riding stimulus of a palatable diet has been removed. This is evidenced 
by apparent counter-regulatory changes in hypothalamic gene expression observed in 
DIO animals [4,7,8]. Thus genes which show a characteristic response to negative 
energy balance, such as following food restriction, exhibit the opposite response to 
DIO, e.g. suppression of orexigenic gene expression in obese hypercaloric rats.  
 
The mechanistic basis of hypocaloric intake upon withdrawal of palatable food is 
poorly defined. We employed the simplified dietary manipulation of EN 
supplementation of control diet [9] in order to maximise the effect sizes of both 
hypercaloric intake with palatable diet and reduced voluntary intake upon its 
withdrawal. We compared rats in which EN access was terminated (EN-C) with those 
held on control diet throughout but pair-fed (C-PF) to the energy intake of EN-C rats 
over the post-EN period. To our knowledge this is the first assessment of 
hypothalamic and forebrain regulatory systems that have been implicated in negative 
energy balance, DIO and food reward during this acute dietary transition phase. We 
hypothesised that despite equicaloric intake, energy balance and/or reward systems 
would differentiate between voluntary hypocaloric intake and imposed restriction.  
 
2. Materials and Methods 
2.1 Animals  
Procedures were licensed under the UK Animals (Scientific Procedures) Act and 
received local ethical approval. SD rats (Charles River Laboratories, Kent, UK) were 
housed individually at 19-21°C on a 12:12h light-dark cycle and fed Purina 5001 
(control diet; 3.34kcal/g: 23% protein, 12% fat, 65% carbohydrate by energy; PMI 
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Nutrition International, Nottingham, UK) ad libitum. Where detailed, control diet was 
supplemented with liquid chocolate Ensure (EN; 1.06kcal/ml: 14% protein, 22% fat, 
64% carbohydrate; Abbott Nutrition, Abbott Laboratories Ltd., Kent, UK), also 
available ad libitum, and renewed daily. Dietary regimes were initiated at a body 
weight of c. 200g. 
 
Study 1: Energy intake and body weight gain were recorded for 20 rats (EN-C) during 
baseline feeding on control diet (30 days), while control diet was supplemented with 
EN (70 days), and following the withdrawal of EN (28 days). Controls (C-C) were fed 
control diet throughout. The EN supplementation period of 10 weeks was selected to 
approximate to the duration of dietary manipulation used in Levin and Keesey’s 
original study [2], and in our earlier study [4], in both of which EN was provided as a 
supplement to HE diet. This regime was intended to give rise to similar body weight 
differentials (c. 100g), and energy intake responses upon withdrawal, to those 
previously reported. 
 
Study 2: Using a similar study design, rats were fed control diet ad libitum before 
being divided into 3 weight-matched groups, each of 30 rats, one of which had control 
diet supplemented with EN for 73 days (EN-C). At the end of this period, EN was 
withheld in the first half of the light phase; control diet continued to be available ad 
libitum. EN-C rats were killed by decapitation in two sub-groups after a further 24 
hours or 4 days. The weight of control diet eaten during the previous 24 hours by 
individual EN-C rats, with EN withheld, was used to pair feed identified individuals 
in one of the control diet-fed groups (C-PF). The restricted ration was delivered in the 
second half of the light phase. Rats in the remaining control diet-fed group (C-C) 
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were fed ad libitum throughout and killed in two sub-groups 24 hours after C-PF 
animals. Serum and plasma were prepared from trunk blood. Brains were frozen for in 
situ hybridisation. The following tissues were dissected and weighed: subcutaneous, 
epididymal, retroperitoneal, omental and mesenteric white adipose tissue (WAT), 
interscapular brown adipose tissue (IBAT) and liver. IBAT was dissected free from 
any visible adhering WAT prior to weighing. 
 
2.2 Blood parameters 
Serum leptin concentrations were measured using a rat-specific radioimmunoassay kit 
(Linco; RL-83K, Biogenesis, Poole, Dorset, U.K.). Plasma insulin was measured 
using a rat-specific radioimmunoassay kit (Linco; RI-13K; Biogenesis). Plasma 
glucose was determined using the KONE analyser. 
 
2.3 Gene expression  
Expression of energy balance and feeding related genes was quantified in the 
hypothalamus or forebrain using in situ hybridisation, as described in detail elsewhere 
[3,4,7,8]. Riboprobes complementary to partial fragments of neuropeptide Y (NPY), 
agouti related peptide (AgRP), proopiomelanocortin (POMC), cocaine and 
amphetamine-regulated transcript (CART), leptin receptor (ObRb), dynorphin (DYN), 
enkephalin (ENK), suppressor of cytokine signalling-3 (SOCS3), melanocortin-3 
receptor (MC3R), dopamine D2/D3 receptors (D2R, D3R), and cannabinoid type 1 
receptor (CB1R) were generated from cloned cDNAs. Brain sections (20 micron) were 
collected from the caudal extent of the hypothalamic arcuate nucleus (ARC) rostrally 
onto a set of 10 slides and from the forebrain caudally onto two sets of 10 slides. Sets 
of slides spanned the ARC from approximately –4.52 mm to –2.30mm, and the 
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forebrain, from 2.28mm to 0.36mm relative to Bregma [10]. Sections were fixed, 
acetylated (except for POMC, CART and NPY), and hybridised overnight at 58C 
using 
35
S-labelled antisense riboprobes (10
7
 dpm/ml). Processed slides were apposed 
to Kodak Biomax MR film (Sigma, UK). Autoradiographic images were quantified 
using a computerised image analysis system, the Image-Pro Plus system (Media 
Cybernetics, Maryland, USA). Scanned images from sheet film were analysed at the 
level of individual nuclei or identified forebrain regions, measuring the intensity and 
area of the hybridisation signal. The integrated intensity of the hybridization signal 
was then computed using set parameters and standard curves generated from 
14
C 
autoradiographic microscales (Amersham, UK). Image analysis was performed on 4 
or 5 representative sections from each brain region, by an observer blind to the 
treatment groups.  
 
2.4 Statistical analysis 
Mean values are reported  S.E.M. and statistical significance was set as P<0.05. 
Tissue weights, blood parameters and gene expression were analysed by two-way 
ANOVA using SigmaStat v3.1 (Jandel Corporation, Ergath, Germany), with dietary 
manipulation and time (since withdrawal of Ensure) as factors. For simplicity, 
ANOVA results use the terminology ‘effect of diet’ and ‘effect of time’.  Energy 
intake and body weight gain data were analysed by two-way RM ANOVA. Due to the 
staggered termination of the in vivo study in Study 2 (EN-C, C-PF, C-C), energy 
intake and body weight gain were realigned over the final 4 days for each 
experimental group and compared separate from the pre-withdrawal data.   
 
3. Results 
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3.1 In vivo measures 
Study 1: Supplementation with EN (EN-C) resulted in an immediate and sustained 
increase in total energy intake (Fig. 1A). Intake was maximal during the initial 2 
weeks following supplementation before declining to a plateau that represented an 
excess energy intake of approximately 20% compared to C-C. Withdrawal of EN 
resulted in an immediate reduction in energy intake to 36% of C-C intake or 31% of 
the final supplemented level, before intake recovered slowly over a period of 3-4 
weeks. Energy intake was elevated in EN-C rats (n=20) between day 32 and day 101 
(P generally <0.001, but NS on days 51, 64-66, 74, 78, 85, 86, 97 and 102; Fig. 1A – 
significant difference indicated by filled bar), but was depressed relative to C-C 
between day 103 and day 116 (P generally <0.001 – shaded bar), but not from day 
120 onwards, as energy intakes converged. Over the 10 weeks of supplementation, 
EN induced a body weight differential of 110g (Fig. 1B). Body weight gain differed 
between the EN-C and C-C groups from day 59 to day 111 (Fig. 1B – filled bar; 
including P<0.001 from day 79 to day 106), but not from day 112 onwards. The 
recovery in energy intake in the EN-C group combined with the maintenance of 
normal intake and weight gain in the C-C group, resulted in approximately 62% of 
body weight differential between the two groups being lost by the end of the study.  
 
Based on these findings, sampling points of 24h and 4-days following EN withdrawal 
were selected for further study. Samples at the 24h time point correspond to maximal 
(acute) restriction, i.e. >60% vs C-C, whereas the 4-day time point corresponds to the 
last day of at least 50% energy restriction vs C-C.  Although energy intake remains 
supressed beyond this period, daily energy intake gradually increases and dilutes the 
average restriction level. 
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Study 2: Total energy intake of the EN-C group (n=15) during EN supplementation 
was 18% higher than in the control groups (Fig.2A), with 84% of ingested calories 
taken as EN. As in Study 1, there was an immediate reduction in calorie intake when 
EN was withheld, from around 100kcal to 37kcal during the first 24h. Over the 
following 3 days, caloric intake increased only slowly, rising to approximately 50kcal 
by day 4 (Fig. 2A). Energy intake was elevated in EN-C rats compared to C-C from 
day 41 to day 114 (P<0.05, but NS on days 63, 70, 78, 90 and 97; Fig. 2A – filled 
bar). Over the final 4 days of the study, daily energy intake was depressed in both EN-
C and C-PF rats compared to C-C rats (all P<0.001; Fig. 2A – shaded bar). Ensure 
supplementation gave rise to a body weight differential of c. 100g immediately prior 
to the withdrawal of EN from the EN-C group (Fig. 2B). Voluntary hypophagia in 
EN-C rats gave rise to body weight losses of 7.7g (1.4%) and 19.6g (3.5%) after 24h 
and 4 days, respectively (Fig. 2B). By comparison, imposed restriction to the same 
caloric intake in the C-PF group resulted in losses of 15.4g (3.4%) and 34.7g (7.5%) 
after 24h and 4 days, respectively. Body weight gain differed between the EN-C and 
C-C groups (EN-C>C-C) from day 54 to day 120 (mostly P<0.001; Fig. 2B – filled 
bar), and remained higher in EN-C compared to both C-C and C-PF following the 
withdrawal of Ensure. 
 
3.2 Post mortem tissue weights 
There were effects of diet (all P<0.001), but not time, for each dissected tissue (Table 
1; n=15). WAT weights were higher in EN-C groups compared to C-C and C-PF 
groups at both time points (all P<0.001), but there were no differences between the 
latter two groups. IBAT weights were higher in EN-C than in C-PF at 24h and 4 days 
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(P<0.001 and P<0.05, respectively). Liver weight was reduced in C-PF groups 
compared to C-C and EN-C, at both time points (all P<0.001).   
 
3.3 Blood hormones and metabolites 
There were effects of diet on all blood parameters (all P<0.01; n=15), but no effects of 
time (Table 2). Blood glucose was lower overall in C-PF rats (P<0.001 vs EN-C; 
P<0.05 vs C-C), with low concentrations at 24h being normalised by day 4. The rank 
order of insulin concentrations was C-C>EN-C>C-PF, with C-C levels being higher 
than EN-C (P<0.05) and C-PF (P<0.001). Leptin levels also differed with all diet 
treatments, reflecting level of adiposity and energy balance state (EN-C>C-C>C-PF); 
statistical outcomes were very similar at 24h and 4 days.  
 
3.4 Gene expression  
There were treatment effects on expression of three of the ARC genes (Fig. 3; n=15). 
The expression profiles for NPY and AgRP were broadly similar, with effects of time 
for both orexigenic genes (day 4>24h; P<0.05 and P<0.01, respectively), and an effect 
of diet for AgRP (P<0.05). For NPY (Fig. 3A), expression levels were elevated at day 
4 (vs 24h) in both EN-C and C-PF groups (P<0.05), whereas for AgRP (Fig. 3B), 
expression levels were higher overall in C-PF rats compared with EN-C rats (P<0.05), 
and also increased with time in C-PF groups (P<0.05). There were no effects on 
expression of the anorexigenic gene, POMC (data not shown), although there was a 
trend towards an effect of diet on CART gene expression (Fig. 3C; P=0.057), where 
mRNA levels in the EN-C groups were elevated relative to the C-C and C-PF groups. 
There was an effect of diet on SOCS3 gene expression (Fig. 3D; P<0.001), due to 
suppression of mRNA levels with pair-feeding (C-PF vs C-C, C-PF vs EN-C, both 
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P<0.001), an effect which was also evident at both 24h and 4 days (all P<0.001 or 
P<0.01). There was also a difference between the C-C and EN-C groups at day 4 (EN-
C>C-C, P<0.05). There were no effects on ObRb or MC3R expression in the ARC, or 
on expression of D2R, D3R, DYN, ENK or CB1R genes in the nucleus accumbens.   
 
4. Discussion 
We assessed hypothalamic and forebrain gene expression correlates of restricted 
intake and weight loss when palatable diet was withheld following the establishment 
of DIO on that diet (EN-C), and compared responses to those of pair-fed rats fed on 
control diet throughout (C-PF). The phenomenon of hypocaloric intake following 
withdrawal of palatable diet has been reported in a number of different models, most 
of them involving solid, cafeteria-type diets [e.g. 5,6,11,12], but in the case of the EN 
model in the SD rat, the use of a palatable liquid has served to highlight the fact that 
not all palatable diets induce these ‘withdrawal-type’ effects – body weight is 
defended and food intake only minimally disturbed by withdrawal of HE pellet diet 
[2,3,4]. Although the withdrawal phase and attendant hypocaloric intake has been 
investigated in the context of anxiety or stress responses [6, 13] or addiction-like 
responses [12], our focus in the current study was on acute regulation of genes related 
to energy balance, leptin signalling and food reward, and the longitudinal 
development of responses over the period of maximal intake suppression following 
diet transition. The hypothalamic changes observed were subtle, but co-ordinated. 
EN-C rats exhibited regulatory changes in energy balance genes that appeared 
designed to counter DIO, but these had dissipated by day 4 following withdrawal, 
with cumulative hypocaloric intake minimising hypothalamic perturbation (vs C-C) 
by this time point, with the exception of SOCS3 gene expression. By contrast, C-PF 
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rats had a hypothalamic profile characteristic of negative energy balance, with 
complementary opposite changes in orexigenic (NPY, AgRP) and anorexigenic 
(CART) peptides, and low levels of SOCS3 gene expression.  
 
For the EN-C group, the experimental protocol represented a simplified dietary 
manipulation compared to those frequently employed with the SD rat DIO model 
[2,4,14] - a regime limited to provision and subsequent withdrawal of EN. The in vivo 
outcomes were typical of similar manipulations described previously [2,4,9,14]. 
Long-term supplementation with EN, and elevated caloric intake (Figs 1A and 2A), 
gave rise to substantial additional body weight gain (Figs 1B and 2B), and increased 
adiposity (Table 1). The proportion of total caloric intake taken as EN was also in line 
with previous reports [4,7,14]. Withdrawal of EN resulted in a sustained reduction in 
energy intake [4,14], and reduction in body weight, although relative overweight 
persisted for many weeks. The hypocaloric intake response to withdrawal of cafeteria-
type diets has been shown to be quite variable in magnitude and duration, with energy 
intake remaining depressed for between 1 and 3 weeks [5,6,11,12]. The data 
generated from Study 1 and Study 2 highlight the robust nature of the Ensure-SD rat 
model. Whereas gene expression responses in the C-PF group were due solely to 
ongoing food restriction, both previous dietary history and current energetic status 
(voluntary restriction) would have contributed to responses in the EN-C group. 
Energy intakes were matched in the EN-C and C-PF groups from the point of 
withdrawal of EN, but the relative reduction in energy intake was greater in the EN-C 
groups. Nevertheless, weight loss outcomes were more severe in the C-PF group, 
presumably reflecting differences in body composition. Another contribution to this 
differential response to the restricted but matched caloric intake could be that the C-
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PF group received their ration within a particular time window (second half of light 
phase), rather than consuming it in an ad libitum pattern, as in the other two groups. 
This makes it likely that there was no food available in the second half of the dark 
phase, possibly accentuating the effect of the overall negative energy balance on C-PF 
outcome measures at the time of tissue sampling. 
 
The genes selected for analysis in the EN-withdrawal/PF phase include energy 
balance genes such as NPY, AgRP and CART, which are regulated by food 
deprivation and food restriction [15,16,17,18], whereby orexigenic genes (e.g. NPY, 
AgRP) are up-regulated and anorexigenic genes (e.g. POMC, CART) are down-
regulated. This creates a hypothalamic drive that favours the restoration of energy 
balance through reduced energy expenditure and hyperphagia once a normal food 
supply is restored. Some of these genes also exhibit apparent counter-regulatory 
changes in the positive energy balance state of DIO (e.g. NPY, AgRP, leptin receptor, 
MC3R [7,8], CART [4,19], melanocortin system [20]). Additional genes relevant to 
leptin signalling (SOCS3), and dopaminergic, opioid and cannabinoid systems in 
forebrain food reward centres [21,22] were also included. Analysis of hypothalamic 
gene expression suggested coordinated regulation of the orexigenic peptides, NPY 
and AgRP, opposite trends for the anorexigenic peptide, CART, and changes in the 
suppressor of cytokine signalling, SOCS3 (Fig. 3). Between 24h and 4 days there was 
only a gradual increase in energy intake, accompanied by continuing weight loss, and 
overall increases in expression of both NPY and AgRP. These differences appeared to 
reflect at least two processes, the normalisation of suppressed expression in EN-C 
rats, and up-regulation in C-PF rats as imposed cumulative energy deficit increased. It 
is notable that the gene expression changes in the current study are quite modest in 
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magnitude compared with some of those reported with complete food deprivation or 
long term food restriction [15,16,17,18], although they are more in line with reported 
responses to DIO and positive energy balance [4,7,8,19,20], the difficulty in 
comparing studies and quantitative methodologies notwithstanding. Since palatability-
induced over-consumption of calories and variable short-medium term caloric 
restriction are arguably more representative of common human experiences, and as 
drivers of our own regulatory processes, more knowledge is required of the relevance 
of such subtle changes. There was no effect of time on either adipose tissue weights 
(Table 1) or leptin levels (Table 2), either between the EN-C groups, or between the 
C-PF groups. Significantly, similar preservation of adipose tissue was observed when 
designated ‘DIO-resistant’ SD rats made obese on a HE+EN diet were transferred 
back to control diet for 2 weeks; rats maintained their elevated adipose tissue mass 
and leptin levels despite a 60% reduction in energy intake and 7% weight loss [2]. 
Reduced caloric intake, and hypoglycaemia in the C-PF group, over the initial 24h of 
restriction did not have a major effect on expression of genes other than SOCS3. 
Initial depression of expression of orexigenic genes in EN-C DIO animals is 
consistent with a pre-existing feedback from excess adipose tissue, i.e. counter-
regulatory in action [4,7,8], although is interesting that this effect was dissipated by 
day 4, even though energy intake remained low, and body adiposity and leptin levels 
unchanged. Thus the trajectories of changes in NPY and AgRP gene expression were 
similar in EN-C and C-PF groups ingesting the same calories from control diet but 
coming from different dietary backgrounds, and with contrasting body composition.  
 
Marked differences were seen between the EN-C and C-PF groups with respect to 
SOCS3 gene expression, which was suppressed in the latter group at both time points, 
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along with insulin and leptin (Table 2). This is consistent with results from fasting 
studies in rats [23], implicating hypoleptinaemia rather than low levels of energy 
intake, and suggesting that SOCS3 gene expression is a more acute marker of food 
restriction than NPY and AgRP. SOCS3 was elevated in hyperleptinaemic EN-C rats 
after 4 days, in line with other data from DIO rodents [e.g. 24], and suggestive of 
leptin resistance [25,26,27], although the absence of equivalent change at 24h, when 
leptin levels were also elevated, was unexpected. As with the neuropeptides, 
expression levels of SOCS3 presumably represent the integration of responses to high 
background leptin levels that reflect body adiposity and the depressive effect of low 
voluntary food intake. 
 
The hypothalamic energy balance system does appear to differentiate between 
voluntary and imposed caloric restriction, with ongoing voluntary restriction in EN-C 
animals pushing hypothalamic indices that reflect DIO back toward a normal baseline, 
whereas the same level of imposed restriction in C-PF animals cumulatively drives 
gene expression towards a compensatory anabolic profile. However, whereas the 
hypothalamic gene expression profile (coupled with hyperleptinaemia) 24h after 
withdrawal of EN seems likely to be responsible for driving down food intake, this 
relationship appears to have broken down by day 4. This would not be predicted from 
the outcome of Study 1, in which energy intake took several more weeks to recover, 
with body weight continuing to decline, albeit at a slower rate, across this period, and 
ultimately settling above the C-C level. By contrast, the trajectories of gene 
expression in the C-PF groups between 24h and day 4 reflected mounting negative 
energy balance, with SOCS3 mRNA and blood leptin levels remaining depressed. The 
longevity of counter-regulatory hypothalamic changes in DIO animals following 
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return to a control diet has not been studied systematically, although analysis in 
animals that had been returned to control diet for 3 weeks revealed an increase in 
NPY and a decrease in CART [4], relative to HE- or HE+EN-fed rats, indicative of 
normalisation of such DIO-related changes. Analysis of hypothalamic neuropeptide 
gene expression in a cafeteria DIO model provides further evidence of up-regulation 
of NPY gene expression upon return to control diet [6]. Sixteen weeks on a cafeteria 
diet resulted in a body weight differential in excess of 100g, driven by a doubling of 
daily energy intake. Withdrawal of cafeteria diet reduced energy intake to a level half 
that of controls, and which increased only gradually over 9 days of control diet 
feeding. Ventral hypothalamus NPY gene expression was significantly higher 9 days 
after withdrawal than in rats that continued to be fed the cafeteria diet [6]. As in the 
SD rat model of DIO [4], this outcome could reflect the normalisation of expression 
levels that had been suppressed by developing DIO. 
 
In addition to apparent ‘recognition’ of excess body weight and adiposity, another 
possible influence on feeding behaviour upon transfer back to the less palatable 
control diet is successive negative contrast (SNC; [5]). This effect sees animals 
transferred from a more- to a less-preferred reward perform worse (i.e. in this case, 
consume less calories) than animals that have only ever received the less preferred 
reward. SNC, as it relates to feeding, is observed whether the food reward is presented 
in solid or liquid form [28]. The relative importance of adiposity recognition and SNC 
has been assessed by feeding rats a restricted ration of a cafeteria-type diet to prevent 
development of DIO, prior to transfer back to chow [5]. This manipulation suggested 
that the hypocaloric episode ascribed to SNC was less pronounced and of shorter 
duration (5-7 days) than the counter-regulatory effect of elevated body weight (3-4 
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weeks) observed in DIO rats. Whereas calories in liquid form may contribute to the 
level of over-consumption through reduced satiety and less accurate compensation 
[29], this may not be directly relevant upon withdrawal where the forces in play (body 
composition and SNC) are likely to be independent of the physical form of the 
historically consumed calories. Although the current study was not designed to 
examine the phenomenon of SNC directly, the time scale of normalisation of gene 
expression observed is closer to that presumed for SNC [5], although this seems an 
unlikely relationship. The hedonic, or reward, system is a more likely candidate for 
any SNC effect [30], although our examination of dopamine receptor, cannabinoid 
receptor and opioid genes in the nucleus accumbens at both 24h and 4 days, found no 
evidence of perturbations in expression of these systems, despite studies showing that 
striatal opioid gene expression may be regulated following EN feeding [31], and 
ventral tegumental area up-regulation of dopamine receptor expression on transfer to 
cafeteria diet [6]. 
 
5. Conclusions 
The defence of body weight and regulation of body adiposity, whether through set 
point or some other model, remain areas of active debate [32]. The relationships 
between diet composition and palatability, the development and severity of DIO, and 
the persistence of elevated body weight once dietary transitions are reversed, are 
poorly understood. However, it is apparent that some diets induce body weight gain 
that will be defended completely when dietary palatability is reduced, e.g. on return to 
control diet, whereas others give rise to additional body weight that is only partially 
defended. Here we have obtained foundation data on the hypothalamic correlates of 
acute hypocaloric intake in one of these models, on withdrawal of EN in the SD rat. 
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This manipulation is known to result in a failure to defend elevated DIO body weight 
in unselected populations [4], in selected DIO-resistant rats [2], and in selectively-
bred DIO-sensitive rats [14]. The current study suggests that 24h after withdrawal of 
EN, hypothalamic gene expression primarily reflects ‘inappropriate’ body 
composition, i.e. recognition of excess body adiposity, and removal of the overriding 
stimulus of the palatable diet allows suppression of food intake. However, by day 4, 
although caloric intake is still suppressed, downward body weight trajectory is 
apparently sufficiently well established for the compensatory hypothalamic profile to 
dissipate. Pair-feeding control rats to the level of energy intake voluntarily consumed 
by animals coming off of EN results in neuropeptide gene expression changes with a 
similar trajectory, but which reflect cumulative negative energy balance, with the 
minimal effect at 24h being augmented by 4 days. These findings, and additional 
major differences in effect on SOCS3 gene expression, support the contention that 
energy balance systems differentiate between voluntary and imposed negative energy 
balance where energy intakes are identical, but dietary history, body weight and body 
composition are contrasting. The subtle nature of some of the changes in gene 
expression with the food withdrawal manipulation underlines the need for more 
investigation of the regulation of hypothalamic and food reward systems beyond 
substantial challenges such as complete food deprivation.     
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8. Figure legends 
 
Figure 1. A. Energy intake (kcal/day) and B. body weight gain (g) of rats in Study 1. 
Rats were either fed control diet only throughout (C-C), or were fed control diet for 
30 days followed by control diet supplemented with Ensure (EN) for 70 days, after 
which EN was withheld (EN-C), and control diet only was available for a further 28 
days. Data are meanSEM (n=20/group). Points of diet transition are indicated by 
vertical arrows (broken arrow, introduction of EN supplement; solid arrow, 
withdrawal of EN). The filled and shaded horizontal bars on A indicate phases of 
hypercaloric and hypocaloric energy intake, respectively, in EN-C rats. The filled 
horizontal bar on B indicates the period of significant body weight differential 
between groups. 
 
Figure 2. A. Energy intake (kcal/day) and B. body weight gain (g) of rats in Study 2. 
Rats were either fed control diet only throughout (C-C), or had control diet 
supplemented with EN for 73 days, after which EN was withheld and control diet 
only was available ad libitum for a further 24h or 4 days (EN-C). A third group of rats 
was also fed control diet only ad libitum, but individuals were then pair-fed (C-PF) to 
the weight of control diet eaten during the previous 24 hours by individual EN-C rats. 
Data shown are for the C-C, EN-C and C-PF groups at the 4 day time point, and are 
meanSEM (n=15/group). Points of diet transition are indicated by vertical arrows 
(broken arrow, introduction of EN supplement; solid arrow, withdrawal of EN). The 
filled and shaded horizontal bars on A indicate phases of hypercaloric and hypocaloric 
energy intake, respectively, in EN-C rats. The filled horizontal bar on B indicates the 
period of significantly elevated body weight in the EN-C group. 
 
Figure 3. Gene expression for A. NPY, B. AgRP, C. CART and D. SOCS3 in the 
hypothalamic arcuate nucleus (ARC) of rats from Study 2 subjected to the dietary 
manipulations detailed in the legend to Figure 2. Data are meanS.E.M (n=15/group), 
and are expressed as a percentage of C-C 24hrs. Black lines depict significant 
differences between groups, P<0.05; * P<0.01 or <0.001 vs other groups at same time 
point. Autoradiographs are representative images showing gene expression for A. 
NPY, comparing C-PF rats at 24h and 4-day time points, B. AgRP, using adjacent 
sections to those hybridised for NPY, C. CART, comparing C-C and EN-C at the 24h 
time point, and D. SOCS3, comparing C-C and C-PF at the 24h time point. 
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FIGURE 3 
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